Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

UFP Technologies Inc

Healthcare US UFPT

214.86USD
-0.14(0.07%)

Last update at 2026-03-10T20:00:00Z

Day Range

207.86216.26
LowHigh

52 Week Range

127.29268.34
LowHigh

Fundamentals

  • Previous Close 215.00
  • Market Cap1983.28M
  • Volume213793
  • P/E Ratio41.24
  • Dividend Yield-%
  • EBITDA73.44M
  • Revenue TTM407.33M
  • Revenue Per Share TTM53.32
  • Gross Profit TTM 90.26M
  • Diluted EPS TTM6.27

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 52.72M 21.20M 16.28M 23.65M 18.40M
Minority interest - - - - -
Net income 41.79M 15.89M 13.37M 19.75M 14.31M
Selling general administrative 55.63M 29.48M 27.49M 29.25M 27.76M
Selling and marketing expenses - - - - -
Gross profit 90.26M 51.11M 44.68M 53.96M 48.31M
Reconciled depreciation 11.89M 8.41M 8.27M 8.17M 7.83M
Ebit 21.64M 21.22M 8.56M 16.54M 13.66M
Ebitda 33.53M 30.12M 16.82M 24.71M 21.49M
Depreciation and amortization 11.89M 8.90M 8.27M 8.17M 7.83M
Non operating income net other 0.08M 0.07M -0.36600M -0.38800M 0.11M
Operating income 21.64M 21.22M 8.56M 16.54M 19.61M
Other operating expenses 309.33M 184.69M 162.18M 173.67M 169.91M
Interest expense 2.76M 0.09M 0.08M 0.67M 1.32M
Tax provision 10.93M 5.32M 2.91M 3.90M 4.09M
Interest income - 0.05M 0.00000M 0.00000M 0.05M
Net interest income -2.76300M -0.03900M -0.08300M -0.67400M -1.27300M
Extraordinary items - - - - -
Non recurring -5.12200M 0.42M 0.46M - 0.94M
Other items - - - - -
Income tax expense 10.93M 5.32M 2.91M 3.90M 4.09M
Total revenue 353.79M 206.32M 179.37M 198.38M 190.46M
Total operating expenses 45.80M 29.48M 27.49M 29.25M 27.76M
Cost of revenue 263.53M 155.21M 134.69M 144.42M 142.15M
Total other income expense net 31.08M -0.01300M 7.73M 7.11M -0.87400M
Discontinued operations - - - - -
Net income from continuing ops 41.79M 15.89M 13.37M 19.75M 14.31M
Net income applicable to common shares 41.79M 15.89M 13.37M 19.75M 14.31M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 404.14M 377.54M 334.13M 203.20M 188.76M
Intangible assets 64.12M 68.36M 67.58M 19.72M 20.98M
Earning assets - - - - -
Other current assets 3.43M 3.24M 3.38M 2.56M 2.58M
Total liab 118.05M 140.00M 139.69M 26.31M 26.77M
Total stockholder equity 286.09M 237.54M 194.45M 176.89M 161.99M
Deferred long term liab - - 7.60M 8.87M 2.79M
Other current liab 22.09M 27.12M 13.61M 7.96M 8.48M
Common stock 0.08M 0.08M 0.07M 0.07M 0.07M
Capital stock 0.08M 0.08M 0.07M 0.07M 0.07M
Retained earnings 247.52M 202.60M 160.81M 144.92M 131.55M
Other liab - 22.84M 104.98M 9.67M 7.72M
Good will 113.26M 113.03M 107.91M 51.84M 51.84M
Other assets - 9.23M 14.75M 3.88M 2.92M
Cash 5.26M 4.45M 11.12M 24.23M 3.74M
Cash and equivalents - - - - -
Total current liabilities 58.21M 55.76M 34.71M 15.14M 16.31M
Current deferred revenue 6.62M 4.68M 4.25M 1.89M 2.57M
Net debt 40.77M 50.55M 73.24M -22.02900M -0.65300M
Short term debt 7.22M 4.00M 6.24M 1.17M 0.67M
Short long term debt 4.00M 4.00M 4.00M - -
Short long term debt total 46.04M 55.00M 84.36M 2.21M 3.09M
Other stockholder equity 38.23M 35.48M 33.56M 31.90M 30.36M
Property plant equipment - 58.07M 56.57M 53.76M 56.74M
Total current assets 144.63M 116.35M 87.32M 71.86M 53.25M
Long term investments - - - - -
Net tangible assets - 237.54M 18.96M 105.34M 89.18M
Short term investments - - - - -
Net receivables 65.75M 55.12M 39.38M 26.43M 28.65M
Long term debt 28.00M 51.00M 71.00M - 0.33M
Inventory 70.19M 53.54M 33.44M 18.64M 18.28M
Accounts payable 22.29M 19.96M 10.61M 4.12M 4.58M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.27M -0.61000M - - -59.35000M
Additional paid in capital - - - - -
Common stock total equity - 0.08M 0.07M 0.07M 0.07M
Preferred stock total equity - - - - -
Retained earnings total equity - 202.60M 160.81M 144.92M 131.55M
Treasury stock - -0.58700M -0.58700M -0.58700M -0.58700M
Accumulated amortization - - - - -
Non currrent assets other 5.79M 20.29M 5.43M 6.03M 5.96M
Deferred long term asset charges - - - - -
Non current assets total 259.50M 261.20M 246.81M 131.34M 135.51M
Capital lease obligations 14.04M 13.37M 9.36M 2.21M 3.09M
Long term debt total - - 71.00M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 1.29M -101.45900M -4.26100M -5.77400M -82.32900M
Change to liabilities 16.28M -0.32500M -0.13700M -2.13400M 2.54M
Total cashflows from investing activities 1.29M -101.45900M -4.26100M -5.77400M -82.32900M
Net borrowings -20.00000M 74.84M -0.01100M -25.14300M 25.14M
Total cash from financing activities -25.89400M 74.05M -0.28500M -24.95000M 26.27M
Change to operating activities 2.91M -1.66500M 0.21M 0.35M 1.10M
Net income 41.79M 15.89M 13.37M 19.75M 14.31M
Change in cash -6.66600M -13.11700M 20.49M 0.51M -34.74000M
Begin period cash flow 11.12M 24.23M 3.74M 3.24M 37.98M
End period cash flow 4.45M 11.12M 24.23M 3.74M 3.24M
Total cash from operating activities 17.74M 14.29M 25.04M 31.23M 21.32M
Issuance of capital stock - - - - -
Depreciation 11.89M 8.41M 8.27M 8.17M 7.83M
Other cashflows from investing activities 15.07M -96.06400M 0.11M 0.00400M -76.90100M
Dividends paid - - - - -
Change to inventory -19.60500M -4.49600M -0.36600M 1.30M -2.29500M
Change to account receivables -16.86400M -9.41900M 2.22M -0.32700M -2.55600M
Sale purchase of stock 0.39M 0.16M 0.47M 0.70M 1.27M
Other cashflows from financing activities 37.78M 74.08M 5.23M 0.19M 57.13M
Change to netincome -13.46500M 0.62M 2.40M 2.38M 3.05M
Capital expenditures 13.78M 5.39M 4.37M 5.78M 5.43M
Change receivables -16.86400M -7.75400M 2.22M -0.32700M -2.55600M
Cash flows other operating -2.27600M 1.95M -0.71900M 2.08M -1.55800M
Exchange rate changes - - - - -
Cash and cash equivalents changes -6.85900M -13.11700M 20.49M 0.51M -34.74000M
Change in working capital -22.46600M -10.62600M 1.00M 0.92M -3.86800M
Stock based compensation 3.21M 2.43M 1.81M 1.59M 1.21M
Other non cash items -11.96300M -0.01100M 0.46M -1.05000M -0.04700M
Free cash flow 3.96M 8.90M 20.67M 25.45M 15.89M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
UFPT
UFP Technologies Inc		 -0.14 0.07% 214.86 41.24 22.17 4.37 6.12 4.48 25.97
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

UFP Technologies Inc

100 Hale Street, Newburyport, MA, United States, 01950-3504

Key Executives

Name Title Year Born
Mr. R. Jeffrey Bailly Chairman of Directors, Pres & CEO 1962
Mr. Ronald J. Lataille CFO, Sr. VP & Treasurer 1962
Mr. Christopher P. Litterio Esq. Gen. Counsel, Sec. & Sr. VP of HR 1963
Mr. Mitchell Caplan Rock Pres of MedTech 1968
Mr. Steve Cardin VP & COO of MedTech NA
Mr. R. Jeffrey Bailly CEO & Chairman 1962
Mr. Mitchell Caplan Rock President 1968
Mr. Ronald J. Lataille CFO, Senior VP & Treasurer 1962
Mr. Christopher P. Litterio Esq. General Counsel, Secretary & Senior VP of Human Resources 1963
Mr. Steven G. Cardin VP & COO of MedTech NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.